IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 8,410.00
+240.00 (2.94%)
Feb 19, 2026, 12:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 114.53 billion as of February 18, 2026. Its market cap has decreased by -21.29% in one year.
Market Cap
114.53B
Enterprise Value
91.68B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,410.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 114.53B, a decrease of -77.26%. That is a compound annual growth rate of -54.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 114.53B | -17.39% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| Macrogen | 195.80B |
| ENCell | 183.11B |
| GeneOne Life Science | 140.58B |
| iNtRON Biotechnology | 112.35B |
| CG Invites | 103.12B |